Initiative action of tumor-associated macrophage during tumor metastasis

Saroj Singh1, Neesha Mehta1, Jiang Lilan1

  • 1Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Stomatology, Chongqing Medical University, No. 426 Songshibei Road, Yubei District, Chongqing 401147, China.

Biochimie Open
|February 17, 2018
PubMed

Insights

Tumor-associated macrophages (TAMs) are key players in cancer progression and therapeutic resistance. Targeting TAMs offers a promising strategy for developing novel cancer immunotherapies.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Biology

Background:

  • Tumor-associated macrophages (TAMs) are prevalent in solid tumors, correlating with poor patient outcomes.
  • TAMs can be reprogrammed from a pro-tumor to an anti-tumor phenotype, presenting a therapeutic opportunity.

Purpose of the Study:

  • To review TAM recruitment mechanisms and their roles in tumor angiogenesis, invasion, metastasis, immunosuppression, and chemotherapy resistance.
  • To explore the dual role of Th17 cells and their cytokines within the tumor microenvironment.
  • To discuss TAM-targeting therapies as a novel cancer treatment strategy.

Main Methods:

  • Literature review of mechanisms of TAM recruitment and function.
  • Analysis of the interplay between Th17 cells and other immune cells.
  • Assessment of TAM-targeting therapeutic strategies.

Main Results:

  • TAMs significantly influence tumor progression through angiogenesis, invasion, metastasis, and immune evasion.
  • Th17 cells exhibit both pro-tumorigenic and anti-tumorigenic activities in the tumor microenvironment.
  • Targeting TAMs represents a viable approach for indirect cancer therapy.

Conclusions:

  • Understanding TAMs and Th17 cell dynamics is crucial for advancing cancer immunotherapy.
  • Reprogramming TAMs holds potential for enhancing anti-tumor immunity and overcoming therapeutic resistance.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.6K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K